Please use this identifier to cite or link to this item:
Title: Can post-mastectomy radiation therapy be omitted in T1-2 clinically node-negative breast cancer patients with a positive sentinel lymph node biopsy?
Authors: Dinh, Kate
Soran, Atilla
Işık, Arda
McAuliffe, Priscilla
Diego, Emilia
Sezgin, Efe
Johnson, Ronald
Issue Date: 2019
Publisher: Springer
Abstract: Background/Objective: The AMAROS trial demonstrated that both axillary radiation and axillary lymph node dissection (ALND) provide excellent locoregional control in patients with clinically node-negative T1-2 breast cancers and a positive sentinel lymph node biopsy (+SLNB). In that study, 18% of patients underwent total mastectomy (TM). We evaluate survival outcome of TM patients who do not require additional axillary treatment after identification of a +SLNB.
Description: 20th Annual Meeting of the American-Society-of-Breast-Surgeons -- APR 30-MAY 05, 2019 -- Dallas, TX
ISSN: 1068-9265
Appears in Collections:Food Engineering / Gıda Mühendisliği
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
s10434-019-07407-7.pdf688.83 kBAdobe PDFView/Open
Show full item record

CORE Recommender

Page view(s)

checked on Dec 4, 2023


checked on Dec 4, 2023

Google ScholarTM


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.